Ralph Kern
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ralph Kern
The proxy statement of Brainstorm Cell Therapeutics Inc. reports total compensation of $833,192 for Ralph Kern in fiscal 2023, including a base salary of $29,514. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Brainstorm Cell Therapeutics Inc. (BCLI)
Proxy statement
Start not stated–2023-01-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Brainstorm Cell Therapeutics Inc. (BCLI) | Former President & Former Chief Medical Officer | $29,514 | $833,192 |
| 2022 | Brainstorm Cell Therapeutics Inc. (BCLI) | Former President & Former Chief Medical Officer | $500,000 | $812,559 |
| 2021 | Brainstorm Cell Therapeutics Inc. (BCLI) | Former President & Former Chief Medical Officer | $500,000 | $938,833 |
| 2020 | Brainstorm Cell Therapeutics Inc. (BCLI) | President & Chief Medical Officer | $500,000 | $1,528,281 |
Recent activity
No call appearances or filed executive changes recorded yet.